ACS Combinatorial Science
Letter
hours to reach completation. Notably, less reactive secondary
1{15−19} and alkyl amines 1{11−14} and various arylsulfonyl
chlorides 2{1−5} also worked well in the reaction. All the
products 3−7 were isolated by simple extraction and then
analyzed by GC-MS and NMR spectroscopy. In all cases, the
desired compounds were obtained in excess of 95% purity
without further purification. No cross-contamination was
detected in any instance.
Scale Up. One of the main advantages of flow synthesis is
the easy scaling-up either by continuous running or by the
numbering up of flow reactors. As an example, we have applied
our method for the large preparation of probenecid (10), a
prototypical uricosuric drug also used to treat patients with
renal impairment as an adjunct to antibacterial therapy. The in-
flask patented synthesis of this compound has been reported to
proceed in one or two steps with an overall yield ranging from
41% to 65%.30−32 Thus, 4.4 g of 4-(chlorosulfonyl)benzoic acid
(8) were dissolved in 200 mL of acetone and processed with
5.6 mL of dipropylamine (9) and 3.4 g of NaHCO3 in 200 mL
of a water/PEG 400 solution (Figure 2). The crude flow stream
material ready for biological screenings. Importantly, the
method can be easily automated through the use of an
appropriate software and autosampler. Second, since this
method works efficiently with both primary and secondary
amines and various sulfonyl chlorides, it provides a convenient
route for a wide variety of sulfonamides. Finally, we have
demonstrated the utility of this method for large scale
preparation of probenecid (9) obtained in a single step in
78% yield and purified by precipitation with a purity of 95%.
Moreover, the solvents used can be easily recovered and reused
for further reactions reducing waste, pollution and costs (E-
factor = 0.66).33
ASSOCIATED CONTENT
■
S
* Supporting Information
Description of the experimental procedures, analytical proto-
cols, NMR spectra, and MS data. This material is available free
AUTHOR INFORMATION
■
Corresponding Author
*Address: Laboratory of Medicinal and Advanced Synthetic
Chemistry (Lab MASC), Dipartimento di Chimica e
̀
Tecnologia del Farmaco, Universita di Perugia, Via del Liceo,
+39.075.5855160. Tel: +39.075.5852318.
Author Contributions
The manuscript was written through contributions of all
authors. All authors have given approval to the final version of
the manuscript.
Notes
The authors declare no competing financial interest.
ABBREVIATIONS
■
Figure 2. Flow scale up of probenecib.
PEG, polyethylene glycol; BPR, back pressure regulator
was dropped into an aqueous solution of HCl 3 N (pH< 2)
providing 9 in 78% yield and with a purity greater than 95% by
simple precipitation. The filtered solution was then washed
with diethyl ether, distilled to recycle acetone, and water used
for the reaction, and treated with a solution of NaOH and
Amberlist A15 for the recovery of PEG 400 and of the excess of
amine. Additionally, the ether used in the workup was also
recovered and used in following reactions.
In conclusion, we have developed the synthesis of
sulfonamides by employing flow-based technology to aid the
preparation of a wide variety of compounds and to facilitate the
scale-up operations. This work could therefore support
medicinal chemistry programs at various stages as the hit-to-
lead, lead-optimization and lead candidate scale-up.
Several aspects of this continuous flow process are
noteworthy. First, so far this is the only example of an eco-
benign synthesis of sulfonamide library in a single continuous
step. Reactions were performed at room temperature using an
acetone solution of sulfonyl chlorides along with an aqueous
solution of the amines and NaHCO3, a reagent flow rate of 0.5
mL min−1 and a residence time of approximately 15 min. PEG
400 was essential to achieve the complete solubilization of
organic and inorganic reactants. As previously noted, the
isolation of the desired products was achieved without the use
of column purifications, in high yield and affording quality
REFERENCES
■
(1) Sanz, L. M.; Susanne, F. Continuous Flow Synthesis. A Pharma
Perspective. J. Med. Chem. 2012, 55, 4062−4098.
(2) Baumann, M.; Baxendale, I. R.; Ley, S. V. The Flow Synthesis of
Heterocycles for Natural Product and Medicinal Chemistry
Applications. Mol. Diversity 2011, 15, 613−630.
(3) Wiles, C.; Watts, P. Continuous Flow Reactors: A Perspective.
Green Chem. 2012, 14, 38−54.
(4) Wegner, J.; Ceylan, S.; Kirschning, A. Ten Key Issues in Modern
Flow Chemistry. Chem. Commun. 2011, 47, 4583−4592.
(5) Wilden, J. D. The Sulphonamide Motif as a Synthetic Tool. J.
Chem. Res. 2010, 541−548.
(6) Supuran, C .T.; Casini, A.; Scozzafava, A. Protease Inhibitors of
the Sulfonamide Type: Anticancer, Antiinflammatory, and Antiviral
Agents. Med. Res. Rev. 2003, 5, 535−558.
(7) Scozzafava, A.; Owa, T.; Mastrolorenzo, A.; Supuran, C. T.
Anticancer and Antiviral Sulfonamides. Curr. Med. Chem. 2003, 10,
925−953.
(8) Wright, S. W.; Hallstrom, K. N. A Convenient Preparation of
Heteroaryl Sulfonamides and Sulfonyl Fluorides from Heteroaryl
Thiols. J. Org. Chem. 2006, 71, 1080−1084.
(9) Katritzky, A. R.; Abdel-Fattah, A. A. A.; Vakulenko, A. V.; Tao, H.
N-Sulfonylbenzotriazoles as Advantageous Reagents for C-Sulfonyla-
tion. J. Org. Chem. 2005, 70, 9191−9197.
(10) Caddick, S.; Wilden, J. D.; Judd, D. B. Direct Synthesis of
Sulfonamides and Activated Sulfonate Esters from Sulfonic Acids. J.
Am. Chem. Soc. 2004, 126, 1024−1025.
238
dx.doi.org/10.1021/co400012m | ACS Comb. Sci. 2013, 15, 235−239